PHF5A and bladder transitional cell carcinoma: Figure 5 revealed a notably correlation of PHF5A expression with various immune subtypes in BLCA, BRCA, COAD, HNSC, KIRC, KIRP, LGG, LUSC, LUAD, LIHC, OV, Prostate adenocarcinoma (PRAD), Rectum adenocarcinoma (READ), STAD, TGCT and UCEC.